Merck
The latest news about Merck: headlines, AI summaries and the full story from every source.
- Schwab U.S. Dividend Equity ETF (SCHD) Sees $679M Inflows Amid Strong Performance
- Merck's Personalized Cancer Vaccine Shows Success in Late-Stage Melanoma Trial
- Moderna Stock Surges on Positive Phase 3 Melanoma Trial Results
- Moderna Shares Soar on Cancer Vaccine Results; Target and Lowe's Report Tariff Refund Impacts
- CICC Initiates Coverage on Merck with Outperform Rating
- Merck Discussing Use of Molnupiravir in Response to Ebola Outbreak
- Arm Shares Rally Over 50%, Starbucks Abandons AI Project
- Merck Reports Quarterly Loss Amid Cidara Charge, Sales Rise 5%
- Merck Exceeds Q1 Earnings Estimates with Strong Oncology Sales
- Merck Exceeds Quarterly Estimates with Keytruda and New Products, Adjusts 2026 Guidance
- Merck Shares Rise After Six-Day Losing Streak